Verition Fund Management
ASTH icon

Verition Fund Management’s Astrana Health ASTH Stock Holding History

Verition Fund Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,555
Closed -$634K – 3726
2025
Q4 		$634K Sell
25,555
-4,524
-15% -$120K ﹤0.01% 2480
2025
Q3 		$853K Buy
30,079
+4,748
+19% +$129K ﹤0.01% 2657
2025
Q2 		$630K Buy
+25,331
New +$713K ﹤0.01% 2790
2025
Q1 		– Sell
-28,735
Closed -$906K – 3778
2024
Q4 		$906K Buy
28,735
+9,917
+53% +$471K ﹤0.01% 2118
2024
Q3 		$1.09M Sell
18,818
-6,915
-27% -$340K 0.01% 1829
2024
Q2 		$1.04M Buy
25,733
+19,166
+292% +$760K 0.01% 1644
2024
Q1 		$276K Buy
+6,567
New +$256K ﹤0.01% 2335
2022
Q4 		– Sell
-5,325
Closed -$208K – 2886
2022
Q3 		$208K Buy
+5,325
New +$244K ﹤0.01% 2472

Other funds holding ASTH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return